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etter to the Editor
ow  prevalence  of  human  immunodeﬁciency  virus
nd hepatitis  C virus  co-infection  in a medium  size
ity in southern  Brazil
ear Editor,
pproximately 35.3 million of people are infected with the
uman  immunodeﬁciency virus (HIV) worldwide, and 20–30%
f  them are also contaminated with the hepatitis C virus
HCV).  The introduction of highly active antiretroviral ther-
py  increased the survival time and improved the quality
f  life of HIV-infected individuals, however hepatic diseases
elated  to chronic HCV infection became the main cause
f  morbidity and mortality in these patients.1 The present
ork  aimed to study the prevalence and risk factors for
CV  infection in a sample of HIV-infected patients from
 medium size urban center in the countryside of South
razil.
Adult  individuals with HIV receiving care in a reference out-
atient  treatment center for HIV testing and AIDS treatment
n  Cruz Alta (located in the Northwest region of the state of
io  Grande do Sul, Brazil) were consecutively enrolled in the
tudy  from July 2011 to August 2012. Socio-demographic and
Table 1 – Distribution of socio-demographic and epidemiologica
HCV status.
Variable Total
(n = 148)
Male gender 67 (45.2) 
Age (years) 41.9 ± 11.9 
Education level 
Complete primary education or less 109 (73.6) 
Secondary or higher education 39 (26.3) 
Sexual orientationa
Heterosexual 136 (91.8) 
Homosexual 6 (4.0) 
Bisexual 5 (3.3) 
Possible forms of HIV infectiona,b
Sex 127 (85.8) 
Blood transfusion 7 (4.7) 
Cutting objects 2 (1.3) 
Sharing needles 5 (3.3) 
Time since HIV diagnosis (years)a 6.1 ± 5.6 potential risk factors for HIV infection were obtained with a
standardized  individual questionnaire. General laboratory and
clinical  data were  obtained from the medical records. All par-
ticipants  signed an informed consent form. The study was
approved  by the Research Ethics Committees of the Univer-
sidade  Luterana do Brasil.
A  total of 148 HIV-infected patients were  included in the
study.  Sixteen patients (10.8%) had anti-HCV and HCV-RNA
positive results. A total of 13 patients (81.2%) were  infected
with  HCV genotype 1, and three (18.8%) with genotype 3. Use
of  intravenous drugs and report of possible HIV acquisition
by  sharing needles were  signiﬁcantly higher in co-infected
than in mono-infected patients (p < 0.001) (Table 1). The time
period  since HIV diagnosis was  longer in co-infected than
in  mono-infected patients (p = 0.041). A higher proportion of
HIV/HCV  co-infected patients (100.0%) than mono-infectedl characteristics in HIV-positive patients according to
HCV-negative
(n  = 132)
HCV-positive
(n  = 16)
p
58 (43.9) 9 (56.3) 0.428
41.9 ± 12.2 41.6 ± 8.7 0.898
0.829
97 (73.5) 12 (75.0)
35 (26.5) 4 (25.0)
0.947
120 (90.9) 16 (100.0)
6 (4.5) –
5 (3.8) –
112 (84.8) 15 (93.8) 0.577
6 (4.5) 1 (6.3) 0.931
2 (1.5) – 0.878
1 (0.8) 4 (25.0) <0.001
5.7 ± 5.4 8.9 ± 6.1 0.041
patients (62.1%) had undergone surgery in the past (p = 0.008).
In  the multivariate analysis, use of injecting drugs (p = 0.021),
surgery  history (p < 0.001) and male gender (p < 0.001) were
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Table 1 – (Continued)
Variable Total
(n = 148)
HCV-negative
(n = 132)
HCV-positive
(n = 16)
p
Number of sexual partners in the past 12 monthsa 1.8 ± 2.4 1.8  ± 2.4 2.1 ± 2.2 0.654
Use of condom during last occurrence of sexual intercourse 90 (60.8) 78 (59.1) 12 (75.0) 0.894
Injecting drug use 4 (2.7) – 4 (25.0) <0.001
Smoking drug use 22 (14.8) 19 (14.4) 3 (18.8) 0.823
Snorting drug use 24 (16.2) 19 (14.4) 5 (31.3) 0.511
Blood transfusion 38 (25.6) 33 (25.0) 5 (31.3) 0.910
Tattoo 43 (29.0) 35 (26.5) 8 (50.0) 0.120
Piercing 10 (6.7) 7 (5.3) 3 (18.8) 0.123
Surgery 98 (66.2) 82 (62.1) 16 (100.0) 0.008
Endoscopy 34 (22.9) 32 (24.2) 2 (12.5) 0.941
Sharing toothbrushes 19 (12.8) 17 (12.9) 2 (12.5) 0.928
Sharing sharp objects (in salon, manicure, pedicure, barber and personal care) 61 (41.2) 57 (43.2) 4 (25.0) 0.187
Working in the health service 11 (7.4) 9 (6.8) 2 (12.5) 0.686
STD history 46 (31.0) 38 (28.8) 8 (50.0) 0.265
HAART use 111 (75.0) 99 (75.0) 12 (75.0) 0.847
Note: Variables expressed as number (percentage) or mean ± standard deviation.
STD, sex transmitted disease; HAART, highly active antiretroviral therapy.
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5Bold values are those statistically signiﬁcant (p<0.05), but this empha
a Totals do not coincide due to lack of data from certain participants
b Multiple response.
the independent risk factors associated with HIV/HCV co-
infection.
The  prevalence of HIV/HCV co-infection varies with the
geographic region. In Brazil, reports estimated an average of
20.3%  of HIV/HCV co-infection, ranging from 3.3% to 82.4%
according  to the region.2 Epidemiological studies conducted
in  the capital cities and metropolitan regions from Brazil have
demonstrated  high HIV/HCV co-infection, mainly associated
to  injecting drug use.2 However, epidemiological reports are
sparse  from the countryside, limiting a better understand-
ing  of these epidemiological aspects in Brazil. The present
study  focused in the city of Cruz Alta, a medium size urban
center  with one of the highest incidence rate of HIV/AIDS
in  Rio Grande do Sul.3 HIV/HCV co-infection frequency was
lower  than in the two cities of the metropolitan area of the
state,  Porto Alegre (31.2%) and Canoas (23.8%).4,5 Interest-
ingly  the frequency of injecting drug users was  also lower
in  the investigated population (2.7%) than those reported in
other  studies.4,5 The low HIV/HCV co-infection prevalence
is  probably related to the low frequency of injecting drug
users  in the community. This epidemiologic knowledge is
essential  for the development of speciﬁc prevention strate-
gies  in small and medium size cities from the Brazilian
countryside.
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